DP2AI176896
Project Grant
Overview
Grant Description
Thwart-TB: Testing health workers at risk to advance our understanding of TB infection.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Massachusetts
United States
Geographic Scope
State-Wide
Beth Israel Deaconess Medical Center was awarded
Project Grant DP2AI176896
worth $1,189,520
from the National Institute of Allergy and Infectious Diseases in February 2023 with work to be completed primarily in Massachusetts United States.
The grant
has a duration of 3 years and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Project Grant was awarded through grant opportunity NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 2/21/23
Period of Performance
2/16/23
Start Date
1/31/26
End Date
Funding Split
$1.2M
Federal Obligation
$0.0
Non-Federal Obligation
$1.2M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for DP2AI176896
Additional Detail
Award ID FAIN
DP2AI176896
SAI Number
DP2AI176896-647474644
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NM00 NIH NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
C1CPANL3EWK4
Awardee CAGE
4B998
Performance District
07
Senators
Edward Markey
Elizabeth Warren
Elizabeth Warren
Representative
Ayanna Pressley
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,189,520 | 100% |
Modified: 2/21/23